TPST logo

Tempest Therapeutics, Inc.

TPST
Healthcare|Biotechnology|US
$0.38
+0.01 (+1.44%)
Cash / Share
$0.05

Ownership Breakdown

55.4%
Float
20.0M
Shares Outstanding
11.1M
Float Shares

Major Holders (12)

Combined: 88.4%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Matthew AngelIndividual37.40%5,531,516Mar 25, 202613D/G
Sabby Volatility Warrant Master Fund, Ltd.Corporation9.90%492,223Jan 21, 202613D/G
Hal MintzIndividual9.90%492,223Jan 21, 202613D/G
Sabby Management, LLCCorporation9.90%492,223Jan 21, 202613D/G
Versant Vantage II, L.P.Partnership4.80%2,118,644Feb 11, 202513D/G
Versant Vantage II GP, L.P.Partnership4.80%2,118,644Feb 11, 202513D/G
Versant Vantage II GP-GP, LLCOther4.80%2,118,644Feb 11, 202513D/G
Versant Venture Capital IV, L.P.Partnership2.70%1,171,094Feb 11, 202513D/G
Versant Ventures IV, LLCOther2.70%1,178,471Feb 11, 202513D/G
Versant Venture Capital VI, L.P.Partnership0.50%209,914Feb 11, 202513D/G
Versant Ventures VI GP, L.P.Partnership0.50%209,914Feb 11, 202513D/G
Versant Ventures VI GP-GP, LLCOther0.50%209,914Feb 11, 202513D/G

Insider Trades (100)

Last 4 quarters: 1,829,195 acquired · 787,999 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Horn-Warnock StephanieofficerOct 26, 2026OTHER0——Form 4
Frederick John W.directorOct 13, 2026AWARD25,000$0.74$18.5KForm 4
Frederick John W.directorOct 13, 2026OTHER0——Form 4
Smith Nancy FredadirectorSep 22, 2026AWARD25,000$1.00$25.0KForm 4
Smith Nancy Fredadirector: Sep 22, 2026OTHER0——Form 4
Angel Matthewdirector, 10 percent owner, officer: CEO and PresidentMar 24, 2026BUY231,482$2.16$500.0KForm 4
Angel Matthewdirector, 10 percent owner, officer: CEO and PresidentMar 24, 2026BUY231,482$2.16$500.0KForm 4
Yee John D.directorJun 4, 2026AWARD25,000$1.27$31.8KForm 4
Yee John D.Jun 4, 2026OTHER0——Form 4
Richey William DrakedirectorJun 4, 2026OTHER0——Form 4
Richey William DrakedirectorJun 4, 2026AWARD25,000$1.27$31.8KForm 4
Trojanowski JustinCorporate ControllerMar 31, 2026AWARD22,000$1.64$36.1KForm 4
Maestas NicholasChief Financial OfficerMar 31, 2026AWARD140,000$1.64$229.6KForm 4
Angel Matthewdirector, 10 percent owner, officer: CEO and PresidentMar 24, 2026BUY231,482$2.16$500.0KForm 4
Angel Matthewdirector, 10 percent owner, officer: CEO and PresidentFeb 4, 2026AWARD269,621$2.38$641.7KForm 4
Angel Matthewdirector, 10 percent owner, officer: CEO and PresidentFeb 3, 2026OTHER0——Form 4
Simantov RonitdirectorJan 27, 2026AWARD1,230$2.94$3.6KForm 4
NICHOL GEOFFREYdirectorJan 27, 2026AWARD1,230$2.94$3.6KForm 4
RAAB MICHAELdirectorJan 27, 2026AWARD1,230$2.94$3.6KForm 4
Pellizzari Christine AdirectorJan 27, 2026AWARD1,230$2.94$3.6KForm 4
Brady Stephen Rdirector, officer: President and CEOJan 2, 2025AWARD550,000$0.86$473.0KForm 4
Whiting SamuelChief Medical OfficerJan 2, 2025AWARD270,000$0.86$232.2KForm 4
Trojanowski JustinCorporate ControllerJan 2, 2025AWARD30,000$0.86$25.8KForm 4
Maestas NicholasChief Financial OfficerJan 2, 2025AWARD200,000$0.86$172.0KForm 4
Versant Venture Capital VI, L.P.10 percent ownerAug 8, 2024SELL400,000$1.35$540.0KForm 4
Versant Venture Capital VI, L.P.10 percent ownerAug 12, 2024SELL387,999$1.10$427.0KForm 4
Brady Stephen Rdirector, officer: President and CEOJul 3, 2024BUY35,000$2.11$73.8KForm 4
Whiting SamuelChief Medical OfficerJul 2, 2024BUY4,672$2.13$10.0KForm 4
Trojanowski JustinCorporate ControllerJun 28, 2024BUY7,500$2.16$16.2KForm 4
Pellizzari Christine AdirectorJun 13, 2024AWARD16,000$3.03$48.5KForm 4
NICHOL GEOFFREYdirectorJun 13, 2024AWARD16,000$3.03$48.5KForm 4
Simantov RonitdirectorJun 13, 2024AWARD16,000$3.03$48.5KForm 4
RAAB MICHAELdirectorJun 13, 2024AWARD16,000$3.03$48.5KForm 4
Brady Stephen Rdirector, officer: President and CEOJan 3, 2024AWARD250,000$4.66$1.2MForm 4
Whiting SamuelChief Medical OfficerJan 3, 2024AWARD100,000$4.66$466.0KForm 4
Trojanowski JustinPrincipal Accounting OfficerJan 3, 2024AWARD26,500$4.66$123.5KForm 4
Maestas NicholasVP of Strategy and FinanceJan 3, 2024AWARD40,000$4.66$186.4KForm 4
Brady Stephen Rdirector, officer: President and CEOOct 11, 2023AWARD725,000$9.77$7.1MForm 4
Trojanowski JustinCorporate ControllerOct 11, 2023AWARD55,000$9.77$537.4KForm 4
Whiting SamuelChief Medical OfficerOct 11, 2023AWARD325,000$9.77$3.2MForm 4
Maestas NicholasVP of Strategy and FinanceOct 11, 2023AWARD100,000$9.77$977.0KForm 4
RAAB MICHAELdirectorJun 15, 2023AWARD8,200$1.42$11.6KForm 4
NICHOL GEOFFREYdirectorJun 15, 2023AWARD8,200$1.42$11.6KForm 4
Pellizzari Christine AdirectorJun 15, 2023AWARD8,200$1.42$11.6KForm 4
Simantov RonitdirectorJun 15, 2023AWARD8,200$1.42$11.6KForm 4
Whiting SamuelChief Medical OfficerJan 3, 2023AWARD69,700——Form 4
Dubensky Thomas W.PresidentJan 3, 2023AWARD102,700——Form 4
Brady Stephen RChief Executive OfficerJan 3, 2023AWARD177,300——Form 4
Maestas NicholasVP of Strategy and FinanceJan 3, 2023AWARD38,425——Form 4
Trojanowski JustinCorporate ControllerJan 3, 2023AWARD20,300——Form 4
Trojanowski JustinCorporate ControllerOct 3, 2022AWARD2,500——Form 4
Trojanowski JustinCorporate ControllerSep 30, 2022DISPOSED10,000$2.29$22.9KForm 4
Lorenzo PierreCorporate ControllerJun 21, 2022AWARD8,477——Form 4
Maestas NicholasVP of Strategy and FinanceJun 21, 2022AWARD51,270——Form 4
Whiting SamuelChief Medical OfficerJun 22, 2022AWARD55,680——Form 4
Dubensky Thomas W.director, officer: PresidentJun 21, 2022AWARD87,801$2.35$206.3KForm 4
Dubensky Thomas W.PresidentJun 21, 2022AWARD87,801——Form 4
Brady Stephen RChief Executive OfficerJun 21, 2022AWARD173,533——Form 4
Pellizzari Christine Adirector: Jun 17, 2022AWARD3,500——Form 4
NICHOL GEOFFREYdirectorJun 17, 2022AWARD3,500$2.08$7.3KForm 4
NICHOL GEOFFREYdirector: Jun 17, 2022AWARD3,500——Form 4
Woiwode ThomasdirectorJun 17, 2022AWARD3,500$2.08$7.3KForm 4
Woiwode Thomasdirector: Jun 17, 2022AWARD3,500——Form 4
Simantov Ronitdirector: Jun 17, 2022AWARD3,500——Form 4
RAAB MICHAELdirector: Jun 17, 2022AWARD3,500——Form 4
Woiwode Thomasdirector: Apr 29, 2022BUY2,118,644$2.36$5.0MForm 4
Versant Venture Capital VI, L.P.10 percent owner: Apr 29, 2022OTHER0——Form 4
Versant Vantage II, L.P.10 percent ownerApr 29, 2022DISPOSED0——Form 4
Dubensky Thomas W.director, officer: PresidentJan 7, 2022BUY2,000$4.78$9.6KForm 4
Whiting SamuelChief Medical OfficerJan 6, 2022BUY1,700$4.80$8.2KForm 4
Rock Springs Capital Management LP10 percent ownerDec 30, 2021OTHER0——Form 4
Rock Springs Capital Management LP10 percent ownerDec 30, 2021OTHER0——Form 4
Lorenzo PierreCorporate ControllerJan 4, 2022AWARD6,500$5.45$35.4KForm 4
Maestas NicholasVP of Strategy and FinanceJan 4, 2022AWARD19,500$5.45$106.3KForm 4
Whiting SamuelChief Medical OfficerJan 4, 2022AWARD29,000$5.45$158.1KForm 4
Brady Stephen Rdirector, officer: Chief Executive OfficerJan 4, 2022AWARD94,500$5.45$515.0KForm 4
Dubensky Thomas W.director, officer: PresidentJan 4, 2022AWARD53,100$5.45$289.4KForm 4
RAAB MICHAELdirectorSep 21, 2021AWARD6,635$15.15$100.5KForm 4
Pellizzari Christine AdirectorJul 1, 2021AWARD6,635$11.07$73.4KForm 4
Woiwode ThomasdirectorJul 1, 2021AWARD6,635$11.07$73.4KForm 4
Simantov RonitdirectorAug 6, 2021AWARD6,635$13.60$90.2KForm 4
Simantov Ronitdirector: Aug 6, 2021OTHER0——Form 4
Maestas NicholasVP of Strategy and FinanceJul 12, 2021AWARD23,225$24.19$561.8KForm 4
Maestas NicholasofficerJul 12, 2021OTHER0——Form 4
Versant Venture Capital VI, L.P.10 percent ownerJun 25, 2021OTHER0——Form 4
Versant Venture Capital VI, L.P.10 percent ownerJun 25, 2021DISPOSED0——Form 4
Versant Venture Capital VI, L.P.10 percent ownerJun 25, 2021OTHER0——Form 4
Xu StellaJul 1, 2021AWARD6,635$11.07$73.4KForm 4
NICHOL GEOFFREYJul 1, 2021AWARD6,635$11.07$73.4KForm 4
Pellizzari Christine AJul 1, 2021OTHER0——Form 4
Whiting SamuelJun 25, 2021AWARD540,231$26.40$14.3MForm 4
Whiting SamuelJun 25, 2021AWARD61,945$5.90$365.5KForm 4
Whiting SamuelJun 25, 2021AWARD3,018$10.25$30.9KForm 4
Whiting SamuelJun 25, 2021AWARD201$1.06$213.06Form 4
Whiting SamuelJun 25, 2021OTHER0——Form 4
Xu StellaJun 25, 2021AWARD579,710$1.06$614.5KForm 4
Dubensky Thomas W.Jun 25, 2021AWARD1,000,000$26.40$26.4MForm 4
Dubensky Thomas W.Jun 25, 2021AWARD111,343$1.06$118.0KForm 4
Dubensky Thomas W.Jun 25, 2021AWARD45,988$5.90$271.3KForm 4
Dubensky Thomas W.Jun 25, 2021AWARD36,263$4.97$180.2KForm 4